USFDA gives nod to Pfizer’s drug therapy for patients with Hemophilia – Healthcare News
The U.S. Food and Drug Administration (USFDA) approved Hympavzi (marstacimab-hncq) for patients suffering from Hemophilia A or B. According to...
Pfizers
The U.S. Food and Drug Administration (USFDA) approved Hympavzi (marstacimab-hncq) for patients suffering from Hemophilia A or B. According to...
